Performance data is updated to 28 February 2026.

iShares Global Healthcare ETF

The fund aims to provide investors with the performance of the S&P Global 1200 Healthcare Sector IndexTM, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or small-capitalisation stocks.

Link to website

Stock Code

IXJ

Fund Manager

iShares

AUM

$1.36B

MER (%)

0.41%

Listing Date

11/03/2009

Asset Class

Equities

1 month

0.19%

1 year

-3.84%

3 years

20.11%

5 years

53.96%

Investment Focus

Themes

Health

Exposure Regions

World

Portfolio Breakdown

Top 10 Holdings (100.00% of total assets)

Symbol	Company Name	% assets
IXJ	ISHARES GLOBAL HEALTHCARE ETF TRUS	99.95%
USD	USD CASH	0.15%
AUD	AUD CASH	-0.1%

Sector	Allocation	% assets
Health Care		99.58%
Cash and/or Derivatives		0.4%
Other		0.02%

Similar ETFs

Stock	Name	Fund Manager	AUM $	Listing Date	Asset Class	MER %	1 Year %
AVTG	Avantis Global Equity Active ETF	Avantis	$0	01/10/2025	Equities	0.30%
AVTS	Avantis Global Small Cap Value Active ETF	Avantis	$0	01/10/2025	Equities	0.49%
ARMR	Global Defence ETF	Betashares	$256.61M	04/10/2024	Equities	0.55%	+47.71%
AGX1	Antipodes Global Value Active ETF	Antipodes	$0	07/11/2018	Equities	1.10%	+20.72%
ATOM	Global X Uranium ETF	Global X	$138.98M	07/12/2022	Equities	0.69%	+101.39%

Disclaimer

The information provided on ReviewETF.com.au is intended for general information and comparison purposes only. It is compiled and presented on a best-endeavours basis from publicly available sources, but we do not guarantee its accuracy, completeness, timeliness, or suitability for any particular purpose.

No content on this website constitutes financial advice, investment recommendation, solicitation, or an offer to buy or sell any securities. Past performance is not indicative of future results, and all investments carry risk, including the potential loss of capital.

The point of truth for any ETF is always the official product disclosure statement (PDS), website, and announcements from the ETF issuer/provider (e.g., Vanguard, BetaShares, iShares, VanEck, etc.). We link directly to these primary sources on each individual ETF page wherever possible—please verify all details there before making any decisions.

ReviewETF.com.au, its owner (Joshua), and any associated entities disclaim all liability for any loss or damage arising from the use of, or reliance on, information contained on this site. Users should seek independent professional financial advice tailored to their personal circumstances.

This website may contain links to third-party sites; we are not responsible for their content or privacy practices.

Last updated: January 2026